Rowinsky, E K <br/><br/>
Phase I and pharmacologic study of paclitaxel and cisplatin with granulocyte colony-stimulating factor: neuromuscular toxicity is dose-limiting.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Oct 1993 
 - 2010-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1993.11.10.2010  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Diseases--chemically induced<br/>Cisplatin--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Female<br/>Granulocyte Colony-Stimulating Factor--therapeutic use<br/>Humans<br/>Least-Squares Analysis<br/>Male<br/>Middle Aged<br/>Neoplasms--drug therapy<br/>Neuromuscular Diseases--chemically induced<br/>Paclitaxel--administration & dosage